Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 25 citing Gribble: Randomized dose ranging study of the reduction of fasting and postprandial glucose.... (0.10 sec) 

Effect of whey on blood glucose and insulin responses to composite breakfast and …

- cnfindpark.cn
AH Frid, M Nilsson, JJ Holst, IME Bjorck - American Journal of Clinical …, 2005 - ajcn.cnfindpark.cn
Design:Fourteen diet-treated subjects with type 2 diabetes were served a high-GI breakfast
(white bread) and subsequent high-GI lunch (mashed potatoes with meatballs). The breakfast
and lunch meals were supplemented with whey on one day; whey was exchanged for ...
Cited by 48 - Related articles - BL Direct - All 9 versions

Clinical significance of targeting postprandial and fasting hyperglycemia in …


V Fonseca - Current Medical Research and Opinion®, 2003 - informahealthcare.com
Measurement of glycosylated hemoglobin (HbA1C) remains the gold standard for the assessment
of glycemic control in patients with type 2 diabetes. Recent investigations have studied the correlations
between HbA1C levels and other aspects of glucose metabolism, specifically, ...
Cited by 31 - Related articles - BL Direct - All 8 versions

Nateglinide, a D-Phenylalanine Derivative Lacking Either a Sulfonylurea or …

- aspetjournals.org
M Chachin, M Yamada, A Fujita, T Matsuoka, K … - Journal of Pharmacology …, 2003 - ASPET
A novel antidiabetic agent, nateglinide, is a D-phenylalanine derivative lacking either a sulfonylurea
or benzamido moiety. We examined with the patch-clamp method the effect of nateglinide on
recombinant ATP-sensitive K + (K ATP ) channels expressed in human embryonic kidney ...
Cited by 22 - Related articles - BL Direct - All 3 versions

Is postprandial glucose control important? Is it practical in primary care settings?


CG Parkin, N Brooks - Clinical Diabetes, 2002 - Am Diabetes Assoc
Large interventional studies have shown that achieving and maintaining near-normal glycemic
levels reduces the risk for microvascular and macrovascular complications in type 2
diabetes. The impact of postprandial glucose on glycemic control has become a topic of ...
Cited by 19 - Related articles - BL Direct - All 2 versions

Should Postprandial Glucose Be Measured and Treated to a Particular Target? …

- diabetesjournals.org
J Davidson - Diabetes Care, 2003 - Am Diabetes Assoc
In August 2001, the American College of Endocrinology (ACE) published its recommendations
for glycemic targets in the management of diabetes. Included in those recommendations was
a target for 2-h postprandial glucose (PPG) of <140 mg/dl; current American Diabetes ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Meglitinide analogues: a review of clinical data focused on recent trials


JF Blickle - Diabetes and Metabolism, 2006 - Elsevier
Glinides represent a chemically heterogeneous new class of insulinsecreting agents characterized
by a rapid onset and short duration of action. They act by closure of the ATP-dependant K
channel. Repaglinide, the only glinide available in France, has an equivalent HbA 1c ...
Cited by 16 - Related articles - BL Direct - All 3 versions

Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or …


SA El-Batran, OME Abdel-Salam, SM Nofal, AR … - Pharmacological …, 2006 - Elsevier
After the treatment, a significant reduction was observed in fasting blood glucose levels in all
groups. Rosiglitazone or metformin were found to exhibit a hypolipidaemic effect in diabetic rats
when administered alone or in combination. In comparison, nateglinide, when used ...
Cited by 10 - Related articles - All 5 versions

[PDF] Diabetes mellitus and its treatment


A Bastaki - INTERNATIONAL JOURNAL OF DIABETES AND …, 2005 - ijod.uaeu.ac.ae
Abstract Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin
secretion, insulin action, or both. Insulin deficiency in turn leads to chronic hyperglycaemia with
disturbances of carbohydrate, fat and protein metabolism. It is the most common ...
Cited by 7 - Related articles - View as HTML - BL Direct - All 2 versions

Acute and long-term effects of nateglinide on insulin secretory pathways


AJ Ball, PR Flatt, NH McClenaghan - British journal of …, 2004 - pubmedcentral.nih.gov
Nateglinide (10–400 μM) stimulated a concentration-dependent increase (P<0.05–P<0.001)
in insulin release at a non-stimulatory (1.1 mM) glucose concentration. The insulinotropic response
to 200 μM nateglinide was increased at 30 mM (P<0.01), but not 5.6–16.7 mM glucose ...
Cited by 8 - Related articles - BL Direct - All 4 versions

[PDF] An algorithm for the treatment of type 2 diabetes in Latin America


AR Chacra, JA Davidson, J Diaz, M Escalante- … - Diabetes Obesity and …, 2005 - diabetes.org.br
Summary: Diabetes is a principal and growing health concern in Latin America, accounting for
significant mortality and morbidities. Large, randomized, prospective trials of various interventional
therapies in patients with both type 1 and type 2 diabetes have demonstrated that ...
Cited by 6 - Related articles - View as HTML - All 6 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google